Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and Cognitive Decline

3,5-dihydroxyphenylglycine has been researched along with Cognitive Decline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barry, RL; Byun, NE; Conn, PJ; Gore, JC; Joffe, ME; Li, B; Lindsley, CW; Luessen, DJ; Maksymetz, J; Niswender, CM	1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and Cognitive Decline

Article	Year
mGlu Cell reports, 2021, 11-02, Volume: 37, Issue:5 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition; Cognitive Dysfunction; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; GABAergic Neurons; Glycine; Interneurons; Male; Memory, Short-Term; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Resorcinols; Schizophrenia; Schizophrenic Psychology; Somatostatin	2021

Article

Year

mGlu

Cell reports, 2021, 11-02, Volume: 37, Issue:5

Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition; Cognitive Dysfunction; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; GABAergic Neurons; Glycine; Interneurons; Male; Memory, Short-Term; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Resorcinols; Schizophrenia; Schizophrenic Psychology; Somatostatin

2021